Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features

Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that is engendering the severe coronavirus disease 2019 (COVID-19) pandemic. The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 binds to the three sub-d...

Full description

Bibliographic Details
Main Authors: Sk. Sarif Hassan, Shinjini Ghosh, Diksha Attrish, Pabitra Pal Choudhury, Alaa A. A. Aljabali, Bruce D. Uhal, Kenneth Lundstrom, Nima Rezaei, Vladimir N. Uversky, Murat Seyran, Damiano Pizzol, Parise Adadi, Antonio Soares, Tarek Mohamed Abd El-Aziz, Ramesh Kandimalla, Murtaza M. Tambuwala, Gajendra Kumar Azad, Samendra P. Sherchan, Wagner Baetas-da-Cruz, Kazuo Takayama, Ángel Serrano-Aroca, Gaurav Chauhan, Giorgio Palu, Adam M. Brufsky
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/24/5906
_version_ 1827700148661125120
author Sk. Sarif Hassan
Shinjini Ghosh
Diksha Attrish
Pabitra Pal Choudhury
Alaa A. A. Aljabali
Bruce D. Uhal
Kenneth Lundstrom
Nima Rezaei
Vladimir N. Uversky
Murat Seyran
Damiano Pizzol
Parise Adadi
Antonio Soares
Tarek Mohamed Abd El-Aziz
Ramesh Kandimalla
Murtaza M. Tambuwala
Gajendra Kumar Azad
Samendra P. Sherchan
Wagner Baetas-da-Cruz
Kazuo Takayama
Ángel Serrano-Aroca
Gaurav Chauhan
Giorgio Palu
Adam M. Brufsky
author_facet Sk. Sarif Hassan
Shinjini Ghosh
Diksha Attrish
Pabitra Pal Choudhury
Alaa A. A. Aljabali
Bruce D. Uhal
Kenneth Lundstrom
Nima Rezaei
Vladimir N. Uversky
Murat Seyran
Damiano Pizzol
Parise Adadi
Antonio Soares
Tarek Mohamed Abd El-Aziz
Ramesh Kandimalla
Murtaza M. Tambuwala
Gajendra Kumar Azad
Samendra P. Sherchan
Wagner Baetas-da-Cruz
Kazuo Takayama
Ángel Serrano-Aroca
Gaurav Chauhan
Giorgio Palu
Adam M. Brufsky
author_sort Sk. Sarif Hassan
collection DOAJ
description Angiotensin-converting enzyme 2 (ACE2) is the cellular receptor for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that is engendering the severe coronavirus disease 2019 (COVID-19) pandemic. The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 binds to the three sub-domains viz. amino acids (aa) 22–42, aa 79–84, and aa 330–393 of ACE2 on human cells to initiate entry. It was reported earlier that the receptor utilization capacity of ACE2 proteins from different species, such as cats, chimpanzees, dogs, and cattle, are different. A comprehensive analysis of ACE2 receptors of nineteen species was carried out in this study, and the findings propose a possible SARS-CoV-2 transmission flow across these nineteen species.
first_indexed 2024-03-10T14:06:18Z
format Article
id doaj.art-d65c5b3319374864b2787c170fbfdcf3
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T14:06:18Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-d65c5b3319374864b2787c170fbfdcf32023-11-21T00:37:47ZengMDPI AGMolecules1420-30492020-12-012524590610.3390/molecules25245906Possible Transmission Flow of SARS-CoV-2 Based on ACE2 FeaturesSk. Sarif Hassan0Shinjini Ghosh1Diksha Attrish2Pabitra Pal Choudhury3Alaa A. A. Aljabali4Bruce D. Uhal5Kenneth Lundstrom6Nima Rezaei7Vladimir N. Uversky8Murat Seyran9Damiano Pizzol10Parise Adadi11Antonio Soares12Tarek Mohamed Abd El-Aziz13Ramesh Kandimalla14Murtaza M. Tambuwala15Gajendra Kumar Azad16Samendra P. Sherchan17Wagner Baetas-da-Cruz18Kazuo Takayama19Ángel Serrano-Aroca20Gaurav Chauhan21Giorgio Palu22Adam M. Brufsky23Department of Mathematics, Pingla Thana Mahavidyalaya, Maligram 721140, IndiaDepartment of Biophysics, Molecular Biology and Bioinformatics, University of Calcutta, Kolkata 700009, IndiaDr. B. R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi (North Campus), Delhi 110007, IndiaApplied Statistics Unit, Indian Statistical Institute, Kolkata 700108, West Bengal, IndiaDepartment of Pharmaceutics and Pharmaceutical Technology, Yarmouk University-Faculty of Pharmacy, Irbid 566, JordanDepartment of Physiology, Michigan State University, East Lansing, MI 48824, USAPanTherapeutics, Rte de Lavaux 49, CH1095 Lutry, SwitzerlandResearch Center for Immunodeficiencies, Pediatrics Center of Excellence, Children’s Medical Center, Tehran University of Medical Sciences, Tehran 1416753955, IranDepartment of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USADoctoral studies in natural and technical sciences (SPL 44), University of Vienna, 1010 Wien, AustriaItalian Agency for Development Cooperation—Khartoum, Sudan Street 33, Al Amarat, Khartoum 825109, SudanDepartment of Food Science, University of Otago, Dunedin 9054, New ZealandDepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 77030, USADepartment of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 77030, USAApplied Biology, CSIR-Indian Institute of Chemical Technology Uppal Road, Tarnaka, Hyderabad 500007, IndiaSchool of Pharmacy and Pharmaceutical Science, Ulster University, Coleraine BT52 1SA, Northern Ireland, UKDepartment of Zoology, Patna University, Patna, Bihar 800005, IndiaDepartment of Environmental Health Sciences, Tulane University, New Orleans, LA 70112, USATranslational Laboratory in Molecular Physiology, Centre for Experimental Surgery, College of Medicine, Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro 21941901, BrazilCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8501, JapanBiomaterials and Bioengineering Lab, Translational Research Centre San Alberto Magno, Catholic University of Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001 Valencia, SpainSchool of Engineering and Sciences, Tecnologico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, Monterrey 64849, Nuevo León, MexicoDepartment of Molecular Medicine, University of Padova, Via Gabelli 63, 35121 Padova, ItalyDivision of Hematology/Oncology, Department of Medicine, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USAAngiotensin-converting enzyme 2 (ACE2) is the cellular receptor for the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) that is engendering the severe coronavirus disease 2019 (COVID-19) pandemic. The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 binds to the three sub-domains viz. amino acids (aa) 22–42, aa 79–84, and aa 330–393 of ACE2 on human cells to initiate entry. It was reported earlier that the receptor utilization capacity of ACE2 proteins from different species, such as cats, chimpanzees, dogs, and cattle, are different. A comprehensive analysis of ACE2 receptors of nineteen species was carried out in this study, and the findings propose a possible SARS-CoV-2 transmission flow across these nineteen species.https://www.mdpi.com/1420-3049/25/24/5906ACE2viral spike receptor-binding domainSARS-CoV-2transmissionbioinformatics
spellingShingle Sk. Sarif Hassan
Shinjini Ghosh
Diksha Attrish
Pabitra Pal Choudhury
Alaa A. A. Aljabali
Bruce D. Uhal
Kenneth Lundstrom
Nima Rezaei
Vladimir N. Uversky
Murat Seyran
Damiano Pizzol
Parise Adadi
Antonio Soares
Tarek Mohamed Abd El-Aziz
Ramesh Kandimalla
Murtaza M. Tambuwala
Gajendra Kumar Azad
Samendra P. Sherchan
Wagner Baetas-da-Cruz
Kazuo Takayama
Ángel Serrano-Aroca
Gaurav Chauhan
Giorgio Palu
Adam M. Brufsky
Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
Molecules
ACE2
viral spike receptor-binding domain
SARS-CoV-2
transmission
bioinformatics
title Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
title_full Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
title_fullStr Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
title_full_unstemmed Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
title_short Possible Transmission Flow of SARS-CoV-2 Based on ACE2 Features
title_sort possible transmission flow of sars cov 2 based on ace2 features
topic ACE2
viral spike receptor-binding domain
SARS-CoV-2
transmission
bioinformatics
url https://www.mdpi.com/1420-3049/25/24/5906
work_keys_str_mv AT sksarifhassan possibletransmissionflowofsarscov2basedonace2features
AT shinjinighosh possibletransmissionflowofsarscov2basedonace2features
AT dikshaattrish possibletransmissionflowofsarscov2basedonace2features
AT pabitrapalchoudhury possibletransmissionflowofsarscov2basedonace2features
AT alaaaaaljabali possibletransmissionflowofsarscov2basedonace2features
AT bruceduhal possibletransmissionflowofsarscov2basedonace2features
AT kennethlundstrom possibletransmissionflowofsarscov2basedonace2features
AT nimarezaei possibletransmissionflowofsarscov2basedonace2features
AT vladimirnuversky possibletransmissionflowofsarscov2basedonace2features
AT muratseyran possibletransmissionflowofsarscov2basedonace2features
AT damianopizzol possibletransmissionflowofsarscov2basedonace2features
AT pariseadadi possibletransmissionflowofsarscov2basedonace2features
AT antoniosoares possibletransmissionflowofsarscov2basedonace2features
AT tarekmohamedabdelaziz possibletransmissionflowofsarscov2basedonace2features
AT rameshkandimalla possibletransmissionflowofsarscov2basedonace2features
AT murtazamtambuwala possibletransmissionflowofsarscov2basedonace2features
AT gajendrakumarazad possibletransmissionflowofsarscov2basedonace2features
AT samendrapsherchan possibletransmissionflowofsarscov2basedonace2features
AT wagnerbaetasdacruz possibletransmissionflowofsarscov2basedonace2features
AT kazuotakayama possibletransmissionflowofsarscov2basedonace2features
AT angelserranoaroca possibletransmissionflowofsarscov2basedonace2features
AT gauravchauhan possibletransmissionflowofsarscov2basedonace2features
AT giorgiopalu possibletransmissionflowofsarscov2basedonace2features
AT adammbrufsky possibletransmissionflowofsarscov2basedonace2features